9,900 Shares in CVS Health Corporation $CVS Acquired by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in CVS Health Corporation (NYSE:CVS) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 9,900 shares of the pharmacy operator’s stock, valued at approximately $786,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Edgestream Partners L.P. purchased a new position in CVS Health in the second quarter valued at $432,000. Beacon Pointe Advisors LLC increased its holdings in shares of CVS Health by 3.0% in the second quarter. Beacon Pointe Advisors LLC now owns 18,472 shares of the pharmacy operator’s stock valued at $1,274,000 after purchasing an additional 531 shares during the period. Twin Peaks Wealth Advisors LLC purchased a new position in shares of CVS Health during the 2nd quarter worth approximately $36,000. Baird Financial Group Inc. increased its holdings in CVS Health by 3.9% in the second quarter. Baird Financial Group Inc. now owns 297,802 shares of the pharmacy operator’s stock valued at $20,542,000 after buying an additional 11,099 shares in the last quarter. Finally, GeoWealth Management LLC increased its holdings in CVS Health by 638.0% during the 2nd quarter. GeoWealth Management LLC now owns 16,104 shares of the pharmacy operator’s stock valued at $1,111,000 after acquiring an additional 13,922 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Piper Sandler cut their price target on CVS Health from $101.00 to $99.00 and set an “overweight” rating for the company in a report on Tuesday, March 31st. Truist Financial set a $100.00 price objective on CVS Health in a report on Wednesday, December 10th. JPMorgan Chase & Co. upped their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Bank of America reduced their price objective on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research note on Tuesday, January 27th. Finally, Robert W. Baird increased their target price on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $94.95.

CVS Health Stock Up 0.1%

Shares of CVS Health stock opened at $73.57 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The firm has a market cap of $93.59 billion, a P/E ratio of 53.31, a P/E/G ratio of 0.77 and a beta of 0.51. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15. The business has a 50-day moving average price of $75.74 and a 200 day moving average price of $77.71.

CVS Health (NYSE:CVS) last issued its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the previous year, the firm posted $1.19 earnings per share. CVS Health’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date of this dividend is Thursday, April 23rd. CVS Health’s payout ratio is currently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.